Measuring atopic dermatitis severity in randomized controlled clinical trials: What exactly are we measuring?

Journal of Investigative Dermatology

Volumn 120, Issue 6, 2003, Pages 932-941

  Charman, Carolyn ^a   Chambers, Colette ^a   Williams, Hywel ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

Index; Outcome measures; Severity score

Indexed keywords

ARTICLE; ATOPIC DERMATITIS; CLINICAL EXAMINATION; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE SEVERITY; HUMAN; MEDICAL LITERATURE; OUTCOMES RESEARCH; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; STANDARD;

EID: 0038468539     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2003.12251.x     Document Type: Article

References (116)

1. Abeck D, Andersson T, Grosshans E, et al: Topical application of a platelet-activating factor (paf) antagonist in atopic dermatitis. Acta Derm Venereol 77:449-451, 1997
2. Andersen PH, Bindslev-Jensen C, Mosbech H, Zachariae H, Andersen KE: Skin symptoms in patients with atopic dermatitis using enzyme-containing detergents. A placebo-controlled study. Acta Dermato-Venereol 78:60-62, 1998
3. Anderson C, Lis-Balchin M, Kirk-Smith M: Evaluation of massage with essential oils on childhood atopic eczema. Phytotherapy Res 14:452-456, 2000
4. Andersson AC, Lindberg M, Loden M: The effect of two urea-containing creams on dry, eczematous skill in atopic patients. 1. Expert, patient and instrumental evaluation. J Dermatol Treat 10:165-169, 1999
5. Arkwright PD, David TJ: Intradermal administration of a killed Mycobacterium vaccae suspension (SRL 172) is associated with improvement in atopic dermatitis in children with moderate to severe disease. J Allergy Clin Immunol 107:531-534, 2001
6. Bahmer FA, Schubert HJ: Quantification of the extent and severity of atopic dermatitis: the ADASI score. Arch Dermatol 127:1239-1240, 1991
7. Barton S, ed.: Clinical Evidence. Issue 5. London: BMJ Publishing Group, 2001
8. Berberian BJ, Breneman DL, Drake LA, et al: The addition of topical doxepin to corticosteroid therapy: An improved treatment regimen for atopic dermatitis. Int J Dermatol 38:145-148, 1999
9. Berth-Jones J: Six-Area, Six-Sign Atopic Dermatitis (SASSAD) severity score: A simple system for monitoring disease activity in atopic dermatitis. Br J Dermatol 135 (Supp. 148):25-30, 1996
10. Biagi PL, Bordoni A, Hrelia S, et al: The effect of γ-linolenic acid on clinical status, red cell fatty acid composition and membrane microviscosity in infants with atopic dermatitis. Drugs Exp Clin Res 20:77-84, 1994
11. Bleehen SS, Chu AC, Hamann I, Holden C, Hunter JA, Marks R: Fluticasone propionate 0.05% cream in the treatment of atopic eczema: A multicentre study comparing once-daily treatment and once-daily vehicle cream application versus twice-daily treatment. Br J Dermatol 133:592-597, 1995
12. Boguniewicz M, Fiedler VC, Raimer S, Lawrence ID, Leung DY, Hanifin JM: A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. Pediatric Tacrolimus Study Group. J Allergy Clin Immunol 102 (4 Part 1):637-644, 1998
13. Breneman DL, Hanifin JM, Berge CA, Keswick BH, Neumann PB: The effect of antibacterial soap with 15% triclocarban on Staphylococcus aureus in patients with atopic dermatitis. Cutis 66:296-300, 2000
14. Broberg A, Faergemann J: Topical antimycotic treatment of atopic dermatitis in the head/neck area. A double-blind randomised study. Acta Dermato Venereol 75:40-49, 1995
15. Capella GL, Frigerio E, Altomare G: A randomized trial of leukotriene receptor antagonist montelukast in moderate-to-severe atopic dermatitis of adults. Eur J Dermatol 11:209-213, 2001
16. Gate A, Swinehart JM, Griffin EI, Sutton L, Kaplan A: Azone® enhances clinical effectiveness of an optimized formulation of triamcinolone acetonide in atopic dermatitis. Int J Dermatol 40:232-236, 2001
17. Charman C, Williams HC: Outcome measures of disease severity in atopic eczema. Arch Dermatol 136:763-769, 2000
18. Charman CR, Williams HC: Atopic eczema. In: Barton S ed. Clinical Evidence. Issue 5. London: BMJ Publishing Group, June 2000
19. Charman CR, Venn AJ, Williams HC: Measurement of body surface area involvement in atopic eczema: An impossible task? Br J Dermatol 140:109-111. 1999
20. Charman CR, Venn AJ, Williams HC: Reliability testing of the Six Area, Six Sign Atopic Dermatitis (SASSAD) severity score. Br J Dermatol 146:1057-1060, 2002
21. Costa C. Rilliet A, Nicolet M, Saurat JH: Scoring atopic dermatitis: The simpler the better? Acta Derm Venereol (Stockh) 69:41-45, 1989
22. Czech W, Bräutigam M, Weidinger G, Schöpf E: A body-weight-independent dosing regimen of cyclosporine microemulsion is effective in severe atopic dermatitis and improves the quality of life. J Am Acad Dermatol 42:653-659, 2000
23. Der-Petrossian M, Seeber A, Hönigsmann H, Tanew A: Half-side comparison study on the efficacy of 8-methoxypsoralen bath-PUVA versus narrow-band ultraviolet B phototherapy in patients with severe chronic atopic dermatitis. Br J Dermatol 142:39-43, 2000
24. Diepgen TL: Is the prevalence of atopic dermatitis increasing? In: Williams HC ed. Atopic Dermatitis: the Epidemiology, Causes and Prevention of Atopic Eczema. Cambridge: Cambridge University Press, 2000
25. Drake LA, Fallon JD, Sober A: Relief of pruritus in patients with atopic dermatitis after treatment with topical doxepin cream. The Doxepin Study Group. J Am Acad Dermatol 31:613-616, 1994
26. Drake LA, Cohen L, Gillies R, Flood JG, Riordan AT, Phillips SB, Stiller MJ: Pharmacokinetics of doxepin in subjects with pruritic atopic dermatitis. J Am Acad Dermatol 41:209-214, 1999
27. Ebata T, Izumi H, Aizawa H, Kamide R, Niimura M: Effects of nitrazepam on nocturnal scratching in adults with atopic dermatitis: a double-blind placebo-controlled crossover study. Br J Dermatol 138:631-634, 1998
28. Ehlers A, Stangier U, Gieler U: Treatment of atopic dermatitis: A comparison of psychological and dermatological approaches to relapse prevention. J Consult Clin Psychol 63:624-635, 1995
29. Emerson RM, Williams HC, Allen BR: What is the cost of atopic dermatitis in preschool children? Br J Dermatol 143:514-522, 2001
30. European Task Force on Atopic Dermatitis: Severity scoring of atopic dermatitis: the SCORAD index. Dermatology 186:23-31, 1993
31. Ewing CI, Ashcroft C, Gibbs AC, Jones GA, Conner PJ, David TJ: Flucloxacillin in the treatment of atopic dermatitis. Br J Dermatol 138:1022-1029, 1998
32. Finlay AY: Measurement of disease activity and outcome in atopic dermatitis. Br J Dermatol 135:509-515, 1996
33. Finlay AY, Khan GK: Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 19:210-216, 1994
34. Friedmann PS, Tan BB: Mite elimination - clinical effect on eczema. Allergy 53 (Suppl 48):97-100, 1998
35. Fung AY. Look PC, Chong LY, But PP, Wong E: A controlled trial of traditional Chinese herbal medicine in Chinese patients with recalcitrant atopic dermatitis. Int J Dermatol 38:387-392, 1999
36. Galli E, Chini L, Nardi S. et al: Use of a specific oral hyposensitization therapy to dermatophagoides pteronyssinus in children with atopic dermatitis. Allergol Immunopath (Madr) 22:18-22, 1994
37. Gimenez-Arnau A, Barranco C, Alberola M, Wale C, Serrano S, Buchanan MR, Camarasa JG: Effects of linoleic acid supplements on atopic dermatitis. Adv Exp Med Biol 433:285-289, 1997
38. Gutgesell C, Heise S, Seubert S, Seubert A, Domhof S, Brunner E, Neumann C: Double-blind placebo-controlled house dust mite control measures in adult patients with atopic dermatitis. Br J Dermatol 145:70-74, 2001
39. Hanifin JM: Standardized grading of subjects for clinical research studies in atopic dermatitis: Workshop Report Acta Derm Venereol (Stockh) Suppl 144:28-30, 1989
40. Hanifin JM, Hebert AA, Mays SR., et al: Effects of a low-potency corticosteroid lotion plus a moisturizing regimen in the treatment of atopic dermatitis. Curr Ther Res Clin Exp 59:227-233, 1998
41. Hanifin JM, Ling MR., Langley R, Breneman D, Rafal E: Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: Part 1, Efficacy. J Am Acad Dermatol 44:S28-S38, 2001a
42. Hanifin JM, Thurston M, Omoto M, Cherill R, Tofte SJ, Graeber MEASI Evaluator Group. The eczema area and severity index (EASI): Assessment of reliability in atopic dermatitis. Exp Dermatol 10:11-18, 2001b
43. Harper J: Double-blind comparison of an antiseptic oil-based bath additive (oilatum plus) with regular oilatum (oilatum emmolient) for the treatment of atopic eczema. In: Lever R, Levy J eds. The Bacteriology of Eczema. UK: Royal Society of Medicine Press, 1995
44. Harper JI, Ahmed I, Barclay G, et al: Cyclosporin for severe childhood atopic dermatitis: Short course versus continuous therapy. Br J Dermatol 142:52-58, 2000
45. Hederos CA, Berg A: Epogam evening primrose oil treatment in atopic dermatitis and asthma. Arch Dis Child 75:494-497, 1996
46. Henz BM, Jablonska S, Van de Kerkhof PCM, et al: Double-blind, multicentre analysis of the efficacy of borage oil in patients with atopic eczema. Br J Dermatol 140:685-688, 1999
47. Hiratsuka S, Yoshida A, Ishioka C, Kimata H: Enhancenrent of in vitro spontaneous IgE production by topical steroids in patients with atopic dermatitis. J Allergy Clin Immunol 98:107-113, 1996
48. Hoare C, Li Wan Po A, Williams H: Systematic review of treatments of atopic eczema, Health Technol Assess 4:37, 2000
49. Holland KT, Bojar RA, Cunliffe WJ: A comparison of the effect of treatment of atopic eczema with and without antimicrobial compounds. In: Lever R, Levy J eds. The Bacteriology of Eczema. UK: Royal Society of Medicine Press, 1995
50. Holm L, Öhman S, Bengtsson, Van Hage-Hamsten M, Scheynius A: Effectiveness of occlusive bedding in the treatment of atopic dermatitis - a placebo-controlled trial of 12 months duration. Allergy 56:152-158, 2001
51. Humphreys F, Symons JA, Brown HK, Duff GW, Hunter JAA: The effects of gamolenic acid on adult atopic eczema and premenstrual exacerbation of eczema. Eur J Dermatol 4:598-603, 1994
52. Isolauri E, Sutas Y, Makinen-Kiljunen S, Oja Simo S, Isosomppi R, Turjanmaa K: Efficacy and safety of hydrolyzed cow milk and amino acid-derived formulas in infants with cow milk allergy. J Pediatr 127:550-557, 1995
53. Isolauri E, Arvola T, Sütas Y, Moilanen E, Salminen S: Probiotics in the management of atopic eczema. Clin Exp Allergy 30:1604-1610, 2000
54. Jang I, Yang J, Lee H, Yi J. Kim H, Kim C, Kim T: Clinical improvement and immunohistochemical findings in severe atopic dermatitis treated with interferon γ. J Am Acad Dermatol 142:1033-1040, 2000
55. Jorizzo J, Levy M. Lucky A, et al: Multicenter trial for long-term safety and efficacy comparison of 0.05% desonide and 1% hydrocortisone ointments in the treatment of atopic dermatitis in pediatric patients. J Am Acad Dermatol 33:74-77, 1995
56. Kimata H, Hiratsuka S: Effect of topical etomoglycate solution on atopic dermatitis: Combined treatment of sodium cromoglycate solution with the oral anti-allergic medication, oxatomide. Eur J Pediatr 153:66-71, 1994
57. Koopmans B, Lasthein Andersen B, Mork NJ, Austad J, Suhonen RE: Multicentre randomized double-blind study of locoid lipocream fatty cream twice daily versus locoid lipocream once daily and locobase once daily. J Dermatol Treat 6:103-106, 1995
58. Korting HC, Zienicke H, Braun-Falco O, et al: Modern topical glucocorticoids and anti-infectives for superinfected atopic eczema: Do prednicarbate and didecyldimethylammoniumchloride form a rational combination? [Published erratum appears in Infection 23: 67, 199.5]. Infection 22:390-394, 1994
59. Korting HC, Schafer-Korting M, Klovekom W, Klovekorn G, Martin C, Laux P: Comparative efficacy of hamamelis distillate and hydrocortisone cream in atopic eczema. Eur J Clin Pharmacol 48:461-465, 1995
60. Krutmann J, Diepgen TL, Luger TA, et al: High-dose UVA1 therapy for atopic dermatitis: Results of a multicenter trial. J Am Acad Dermatol 38:589-593, 1998
61. Langeland T, Fagertun HE, Larsen S: Therapeutic effect of loratadine on pruritus in patients with atopic dermatitis. A multi-crossover-designed study. Allergy 49:22-26, 1994
62. La Rosa M, Ranno C, Musarra I, Guglielmo F, Corrias A, Bellanti JA: Double-blind study of cetirizine in atopic eczema in children. Ann Allergy 73:117-122, 1994
63. La Rosa M, Musarra I, Ranno C, et al: A randomized, double-blind, placebo-controlled crossover trial of systemic flunisolide in the treatment of children with severe atopic dermatitis. Curr Ther Res Clin Exp 56:720-726, 1995
64. Latchman Y, Banerjee P, Poulter LW, Rustin M, Brostoff J: Association of immunological changes with clinical efficacy in atopic eczema patients treated with traditional Chinese herbal therapy (zemaphyte). Int Arch Allergy Immunol 109:243-249, 1996
65. Lebwohl M: Efficacy and safety of fluticasone propionate ointment 0.005% in the treatment of eczema. Curtis 57 (2 Suppl.):62-68, 1996
66. Lebwohl M: A comparison of once-daily application of mometasone furoate 0.1% cream compared with twice-daily hydrocortisone valerate 0.2% cream in pediatric atopic dermatitis patients who failed to respond to hydrocortisone. Int J Dermatol 38:604-606, 1999
67. Lever R, MacDonald C, Waugh P, Aitehison T: Randomised controlled trial of advice on an egg exclusion diet in young children with atopic eczema and sensitivity to eggs. Pediatr Allergy Immunol 9:13-19, 1998
68. Lewis-Jones MS, Finlay AY: The Children's Dermatology Life Quality Index (CDLQI): Initial validation and practical use. Br J Dermatol 132:942-949, 1995
69. Lintu P, Savolainen J, Kortekangas-Savolainen O, Kalimo K: Systemic ketoconazole is an effective treatment of atopic dermatitis with IgE-mediated hypersensitivity to yeasts. Allergy 56:512-517, 2001
70. Luger T, Van Leent EJM, Graeber M, et al: SDZ ASM 981: An emerging safe and effective treatment for atopic dermatitis. Br J Dermatol 144:788-794, 2001
71. Mabin DC, Sykes AE, David TJ: Controlled trial of a few foods diet in severe atopic dermatitis Arch Dis Child 73:202-207, 1995a
72. Mabin DC, Hollis S, Lockwood J, David TJ: Pyridoxine in atopic dermatitis. Br J Dermatol 133:764-767, 1995b
73. Majamaa H, Isolauri E: Probiotics: A novel approach in the management of food allergy. J Allergy Clin Immunol 99:179-185, 1997
74. Maloney JM, Morman MR, Stewart DM, Tharp MD, Brown JJ, Rajagopalan R: Clobetasol propionate emollient 0.05% in the treatment of atopic dermatitis. Int J Dermatol 37:142-144, 1998
75. Marchesi E, Rozzoni M, Pini P. Cainelli T: Comparative study of mometasone furoate and betamethasone dipropionate in the treatment of atopic dermatitis. G Ital Dermatol Venereol 129:IX-XII, 1994
76. Marshall M, Lockwood A, Bradley C, Adams C, Joy C, Fenton M: Unpublished rating scales: A source of bias in randomised controlled trials of treatments of schizophrenia? Br J Psychiatry 176:249-252, 2000
77. Moore C, Ehlayel MS, Junprasert J, Sorensen RU: Topical sodium cromoglycate in the treatment of moderate-to-severe atopic dermatitis. Ann Allergy Asthma Immunol 81 (5 Part 1):452-458, 1998
78. Munro CS, Levell NJ, Shuster S, Friedmann PS: Maintenance treatment with cyclosporin in atopic eczema. Br J Dermatol 130:376-380, 1994
79. Niggemann B, Binder C, Dupont C, Hadji S, Arvola T, Isolauri E: Prospective, controlled, multi-center study on the effect of an amino-acid-based formula in infants with cow's milk allergy/intolerance and atopic dermatitis. Pediatr Allergy Immunol 12:78-82, 2001
80. Noh G, Lee K: Successful interferon α therapy in atopic dermatitis of Besnier's prurigo pattern with normal serum IgE and blood eosinophil fraction; randomized case-controlled study. Cytokine 13:124-128, 2001
81. Paller A, Eichenfield LF, Leung DYM, Stewart D, Appell M: A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients. J Am Acad Dermatol 44:S47-S57, 2001
82. Patel P, Gratton D, Eckstein G, Aberer W, Pryzbilla B, Chelly M, Danzig M: A double-blind study of loratadine and cetirizine in atopic dermatitis. J Dermatol Treat 8:249-253, 1997
83. Pei AYS, Chan HHL, Leung TF: Montelukast in the treatment of children with moderate-to-severe ample dermatitis: A pilot study. Pediatr Allergy Immunol 12:154-158, 2001a
84. Pei AYS, Chan HHL, Ho KM: The effectiveness of wet wrap dressings using 0.1% mometasone furoate and 0.005% fluticasone propionate ointments in the treatment of moderate to severe atopic dermatitis in children. Pediatric Dermatol 18:343-348, 2001b
85. Poyner TF, Dass BK: Comparative efficacy and tolerability of fusidic acid/hydrocortisone cream (Fucidin (tm) H cream) and miconazole/hydrocortisone cream (Daktacort (tm) cream) in infected eczema. J Eur Acad Dermatol Venereol 7:S23-S29, 1996
86. Rajka G, Langeland T: Grading of the severity of atopic dermatitis. Acta Derm Venereol (Stockh) 144 (Suppl.):13-14, 1989
87. Ramsay CA, Savoie JM, Gilbert M, Gidon M, Kidson P: The treatment of atopic dermatitis with topical fusidic acid and hydrocortisone acetate. J Eur Acad Dermatol Venereol 7:S15-S22, 1996
88. Reidhav I, Svensson A: Betamethasone valerate versus momerasone furoate cream once daily in atopic dermatitis. J Dermatol Treat 7:87-88, 1996
89. Reynolds NJ, Franklin V, Gray JC. Diffey BL, Farr PM: Narrow-band ultraviolet B and broad-band ultraviolet A phototherapy in adult atopic eczema: a randomised controlled trial. Lancet 357:2012-2016, 2001
90. Ricci G, Patrizi A, Specchia F, Menna L, Bottau P, D'Angelo V, Masi M: Effect of house dust mite avoidance measures in children with atopic dermatitis. Br J Dermatol 143:379-384, 2000
91. Ruzicka T, Bieber T, Schopf E, et al: A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group. N Engl J Med 337:816-821, 1997
92. Sasai-Takedatsu M, Kojima T, Yamamoto A, et al: Reduction of Staphylococcus aureus in atopic skin lesions with acid electrolytic water - a new therapeutic strategy for atopic dermatitis. Allergy 52:1012-1016, 1997
93. Schachner L, Field T, Hernandez-Reif M, Duarte AM, Krasnegor J: Atopic dermatitis symptoms decreased in children following massage therapy. Pediatr Dermatol 15:390-395, 1998
94. Schoni MH, Nikolaizik WH, Schoni-Affolter F: Efficacy trial of bioresonance in children with atopic dermatitis. Int Arch Allergy Immunol 112:238-246, 1997
95. Sears HW, Bailer JW, Yeadon A: Efficacy and safety of hydrocortisone buteprate 0.1% cream in patients with atopic dermatitis. Clin Ther 19:710-719, 1997
96. Serup J: EEMCO guidance for the assessment of dry skin (xerosis) and icthyosis: Clinical scoring systems. Skin Res Technol 1:109-114, 1995
97. Soyland E, Funk J, Rajka G, et al: Dietary supplementation with very long-chain n-3 fatty acids in patients with atopic dermatitis. A double-blind, multicentre study. Br J Dermatol 130:757-764, 1994
98. Stalder JF, Fleury M. Sourisse M, Rostin M, Pheline F, Litoux P: Local steroid therapy and bacterial skin flora in atopic dermatitis. Br J Dermatol 131:536-540, 1994
99. Stiller MJ, Shupack JL, Kenny C, Jondreau L, Cohen DE, Sorer NA: A doubleblind, placebo-controlled clinical trial to evaluate the safety and efficacy of thymopentin as an adjunctive treatment in atopic dermatitis. J Am Acad Dermatol 30:397-602, 1994
100. Tan B, Weald D, Strickland I, Friedmann PS: Double-blind controlled trial of the effect of house dust mite allergen avoidance on atopic dermatitis. Lancet 347:15-18, 1996
101. Thomas KS, Armstrong S, Avery A, Po AL, O'Neill C, Young S, Williams HC: Randomised controlled trial of short bursts of a potent topical corticosteroid versus prolonged use of a mild preparation for children with mild or moderate atopic eczema. Br Med J 324:768-774, 2002
102. Tiling-Grosse S, Rees J: Assessment of area of involvement in skin disease: A study using schematic figure outlines. Br J Dermatol 128:69-74, 1993
103. Traulsen J: Hydrocortisone buteprate versus betamethasone valerate for once-daily treatment of atopic dermatitis. J Dermatol Treat 8:109-114, 1997
104. Tzaneva S, Seeber A, Schwaiger M, Hönigsmann H, Tanew A: High-dose versus medium-dose UVAI phototherapy for patients with severe generalized atopic dermatitis. J Am Acad Dermatol 45:503-507, 2001
105. Valsecchi R, Di Landro A, Pansera B, Reseghetti A: Gammalinolenic acid in the treatment of atopic dermatitis [1]. J Eur Acad Dermatol Venereol 7:77-79, 1996
106. Van Der Meer JB, Glazenburg EJ, Mulder PGH, Eggink HF, Coenraads PJ: The management of moderate to severe atopic dermatitis in adults with topical fluticasone propionate. Br J Dermatol 140:1114-1121, 1999
107. Van Joost TH, Kozel MMA, Tank B, Troost R, Prens EP: Cyclosporine in atopic dermatitis. J Am Acad Dermatol 27:922-928, 1992
108. Van Joost T, Heule F, Korstanje M, van den Brock MJ, Stenveld HJ, van Vloten WA: Cyclosporin in atopic dermatitis: A multicentre placebo-controlled study. Br J Dermatol 130:634-640, 1994
109. Van Leent EJ, Graber M, Thurston M, Wagenaar A, Spuls PI, Bos JD: Effectiveness of the ascomycin macrolactam SDZ ASM 981 in the topical treatment of atopic dermatitis. Arch Dermatol 134:805-809, 1998
110. Veien NK, Kaaber K, Larsen PO, Nielsen AO, Thestrup-Pedersen K: Ranitidine treatment of hand eczema in patients with atopic dermatitis: a double-blind, placebo-controlled trial. J Am Acad Dermatol 32:1056-1057, 1995
111. Ventura A, De Seta L, Martelossi S, et al: Soy allergy and DSCG in atopic eczema: 'much ado about nothing'? Pediatr Med Chir 18:283-288, 1996
112. Williams H, Kobertson C, Stewart A, et al: Worldwide variations in the prevalence of symptoms of atopic eczema in the international study of asthma and allergies in childhood. J Allergy Clin Immunol 103:125-138, 1999
113. Wolkerstorfer A, Strobos MA, Glazenburg EJ, Mulder PGH, Oranje AP: Fluticasone propionate 0.05% cream once daily versus clobctasone butyrate 0.05% cream twice daily in children with atopic dermatitis. J Am Acad Dermatol 39:226-231, 1998
114. Yanase DJ, David-Bajar K: The leukotriene antagonist montelukast as a therapeutic agent for atopic dermatitis. J Am Acad Dermatol 44:89-93, 2001
115. Zonneveld IM. De Rie MA, Beljaards RC. et al: The long-term safety and efficacy of cyclosporin in severe refractory atopic dermatitis: A comparison of two dosage regimens. Br J Dermatol 135 (Suppl. 48):15-20, 1996
116. Zurbriggen B, Wuthrich B, Cachelin AB. Wili PB, Kagi MK: Comparison of two formulations of cyclosporin A in the treatment of severe atopic dermatitis. A double-blind, single-centre, cross-over pilot study. Dermatology 198:56-60, 1999